Journal article
SODIUM-GLUCOSE CO-TRANSPORTER INHIBITORS AND ATRIAL FIBRILLATION: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
Abstract
BACKGROUND Sodium-glucose co-transporter (SGLT) inhibitors reduce heart failure (HF) hospitalization and cardiovascular death in several populations, including patients with type 2 diabetes mellitus, renal impairment, HF and cardiovascular disease. The efficacy of SGLT inhibitors in patients with atrial fibrillation/flutter (AF) and their effect on incidence or recurrence of AF has yet to be systematically assessed. Our objectives were to …
Authors
Pandey A; Okaj I; Kaur H; Belley-Cote E; Oraii A; Benz A; Johnson L; Wong J; Verma S; Conen D
Journal
Canadian Journal of Cardiology, Vol. 37, No. 10, pp. s44–s45
Publisher
Elsevier
Publication Date
October 2021
DOI
10.1016/j.cjca.2021.07.094
ISSN
0828-282X